Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


29.10.2018

1 Am J Gastroenterol
1 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
3 Gastroenterology
4 Hepatology
1 J Clin Microbiol
4 J Hepatol
2 J Infect Dis
2 J Med Virol
6 J Viral Hepat
1 J Virol
1 Lancet Gastroenterol Hepatol
1 PLoS One
1 Transplant Proc
1 Transplantation
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. PAN XB, Lu YQ, Lin SZ, Ye J, et al
    An Assessment of Upper Limits of Normal for ALT and the Impact on Evaluating Natural Course of Chronic Hepatitis B Virus Infection in Chinese Children.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0248.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  2. CHANG ML, Liaw YF
    Gender Impacts on the Disease Severity of Overt Acute Hepatitis A: Different from Overt Acute Hepatitis B.
    Dig Dis Sci. 2018 Oct 25. pii: 10.1007/s10620-018-5340.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  3. SHAH T, Hussain W, Ali N, Sardar S, et al
    Frequency distribution and risk factors of hepatitis B virus and hepatitis C virus infections among thalassemia patients: a regional study.
    Eur J Gastroenterol Hepatol. 2018 Oct 24. doi: 10.1097/MEG.0000000000001287.
    PubMed     Text format     Abstract available

  4. COMBA A, Demirbas F, Caltepe G, Eren E, et al
    Retrospective analysis of children with alpha-1 antitrypsin deficiency.
    Eur J Gastroenterol Hepatol. 2018;30:774-778.
    PubMed     Text format     Abstract available


    Gastroenterology

  5. KIM D, Li AA, Gadiparthi C, Khan MA, et al
    Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
    Gastroenterology. 2018;155:1154-1163.
    PubMed     Text format     Abstract available

  6. BAUMERT TF, Berg T, Lim JK, Nelson DR, et al
    Status of Direct-acting Antiviral Therapy for HCV Infection and Remaining Challenges.
    Gastroenterology. 2018 Oct 17. pii: S0016-5085(18)35155.
    PubMed     Text format     Abstract available

  7. KOH C, Heller T, Glenn JS
    Pathogenesis of and New Therapies for Hepatitis D.
    Gastroenterology. 2018 Oct 18. pii: S0016-5085(18)35162.
    PubMed     Text format     Abstract available


    Hepatology

  8. MUELLER H, Lopez A, Tropberger P, Wildum S, et al
    PAPD5/7 are novel host factors that are required for Hepatitis B virus RNA stabilization.
    Hepatology. 2018 Oct 26. doi: 10.1002/hep.30329.
    PubMed     Text format     Abstract available

  9. LIU S, Zhou B, Valdes JD, Sun J, et al
    Serum HBV RNA: a New Potential Biomarker for Chronic Hepatitis B Virus Infection.
    Hepatology. 2018 Oct 25. doi: 10.1002/hep.30325.
    PubMed     Text format     Abstract available

  10. QUINET J, Jamard C, Burtin M, Lemasson M, et al
    Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks.
    Hepatology. 2018;67:2127-2140.
    PubMed     Text format     Abstract available

  11. CHAUHAN A, Adams DH
    Exercise alters the hepatic immunophenotype to protect against inflammatory liver disease.
    Hepatology. 2017 Nov 16. doi: 10.1002/hep.29657.
    PubMed     Text format    


    J Clin Microbiol

  12. WANG L, Cao X, Wang Z, Gao Y, et al
    HBcrAg correlated with intrahepatic HBV tDNA and cccDNA in HBeAg-positive chronic hepatitis B patients.
    J Clin Microbiol. 2018 Oct 24. pii: JCM.01303-18. doi: 10.1128/JCM.01303.
    PubMed     Text format     Abstract available


    J Hepatol

  13. NISHIBATAKE KINOSHITA M, Minami T, Tateishi R, Wake T, et al
    Impact of direct-acting antivirals on early recurrence of HCV-related HCC: comparison with interferon-based therapy.
    J Hepatol. 2018 Oct 15. pii: S0168-8278(18)32454.
    PubMed     Text format     Abstract available

  14. JI F, Yeo YH, He C, Li J, et al
    Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment.
    J Hepatol. 2018 Oct 15. pii: S0168-8278(18)32390.
    PubMed     Text format    

  15. SCHUCH A, Zecher BF, Muller PA, Correia MP, et al
    NK-cell responses are biased towards CD16-mediated effector functions in chronic Hepatitis B virus infection.
    J Hepatol. 2018 Oct 17. pii: S0168-8278(18)32458.
    PubMed     Text format     Abstract available

  16. IOANNOU GN
    Reply to: "Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment".
    J Hepatol. 2018 Oct 19. pii: S0168-8278(18)32445.
    PubMed     Text format    


    J Infect Dis

  17. LAROUCHE A, Milton McSween KA, Calderon V, Fauteux-Daniel S, et al
    Quasispecies Diversity Is a Major Risk Factor for Vertical Hepatitis C Virus Transmission.
    J Infect Dis. 2018 Oct 25. pii: 5144832. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. THAN TT, Jo E, Todt D, Nguyen PH, et al
    High environmental stability of hepatitis B virus and inactivation requirements for chemical biocides.
    J Infect Dis. 2018 Oct 24. pii: 5144374. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  19. HOLZMAYER V, Hance R, Defechereux P, Grant R, et al
    Identification of Hepatitis B virus genotype I in Thailand.
    J Med Virol. 2018 Oct 23. doi: 10.1002/jmv.25346.
    PubMed     Text format     Abstract available

  20. AZARKAR Z, Ziaee M, Ebrahimzadeh A, Sharifzadeh G, et al
    Epidemiology, risk factors and molecular characterization of occult hepatitis B infection among anti-HBc alone subjects.
    J Med Virol. 2018 Oct 21. doi: 10.1002/jmv.25343.
    PubMed     Text format     Abstract available


    J Viral Hepat

  21. HUANG J, Yin P, Zhang L
    COPII cargo claudin-12 promotes hepatitis C virus entry.
    J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13026.
    PubMed     Text format     Abstract available

  22. CHEVALIEZ S, Rodriguez C, Poiteau L, Soulier A, et al
    Primary Resistance of Hepatitis B Virus to Nucleoside and Nucleotide Analogues.
    J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13025.
    PubMed     Text format     Abstract available

  23. WANG M, Ping Y, Li Z, Li J, et al
    Polarization of granulocytic myeloid-derived suppressor cells by hepatitis C core protein is mediated via IL-10/STAT3 signaling.
    J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13024.
    PubMed     Text format     Abstract available

  24. VAZIRI A, Gimson A, Agarwal K, Aldersley M, et al
    Liver transplant listing for hepatitis C associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct acting antiviral therapy.
    J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13022.
    PubMed     Text format     Abstract available

  25. SARKAR M, Lai JC, Sawinski D, Zeigler TE, et al
    Sex Hormone Levels by Presence and Severity of Cirrhosis in Women With Chronic Hepatitis C Virus (HCV) Infection.
    J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13027.
    PubMed     Text format     Abstract available

  26. GIRARDIN F, Hearmon N, Negro F, Eddowes L, et al
    Increasing Hepatitis C Virus Screening in People Who Inject Drugs in Switzerland Using Rapid Antibody Saliva and Dried Blood Spot Testing: a Cost-Effectiveness Analysis.
    J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13023.
    PubMed     Text format     Abstract available


    J Virol

  27. YI DR, An N, Liu ZL, Xu FW, et al
    Human MxB inhibits the replication of HCV.
    J Virol. 2018 Oct 17. pii: JVI.01285-18. doi: 10.1128/JVI.01285.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  28. PISCAGLIA F, Granito A, Bolondi L
    DAAs for HCV and risk of hepatocellular carcinoma: current standpoint.
    Lancet Gastroenterol Hepatol. 2018;3:736-738.
    PubMed     Text format    


    PLoS One

  29. MARTINEZ-RODRIGUEZ ML, Uribe-Noguez LA, Arroyo-Anduiza CI, Mata-Marin JA, et al
    Prevalence and risk factors of Occult Hepatitis C infections in blood donors from Mexico City.
    PLoS One. 2018;13:e0205659.
    PubMed     Text format     Abstract available


    Transplant Proc

  30. WAZNA E, Pazik J, Perkowska-Ptasinska A, Durlik M, et al
    Does Histopathology of Implanted Kidney According to Banff 07 Help Predict Long-term Transplantation Outcome?
    Transplant Proc. 2018;50:1765-1768.
    PubMed     Text format     Abstract available


    Transplantation

  31. CHARLTON MR, Gane EJ, Shukla A, Dashtseren B, et al
    International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting - From Noncirrhotic to Decompensated Disease and Following Liver Transplantation.
    Transplantation. 2018 Oct 17. doi: 10.1097/TP.0000000000002453.
    PubMed     Text format     Abstract available


    Vaccine

  32. LOPEZ-GATELL H, Garcia-Garcia L, Echaniz-Aviles G, Cruz-Hervert P, et al
    Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31403.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: